ⅢA-N2期非小细胞肺癌根治术后放疗疗效影响因素的研究进展  

Research progress on clinical efficacy of postoperative radiotherapy for resectable pathological stageⅢA-N2 non-small cell lung cancer

作　　者：田翠孟[1] 李宝兰[2] Tian Cuimeng;Li Baolan(Department of Radiotherapy,Beijing Chest Hospital of Capital Medical University,Beijing 101149,China;Department of General Medicine,Beijing Chest Hospital of Capital Medical University,Beijing 101149,China)

机构地区：[1]首都医科大学附属北京胸科医院放疗科,101149 [2]首都医科大学附属北京胸科医院综合科,101149

出　　处：《中华放射肿瘤学杂志》2020年第10期909-912,共4页Chinese Journal of Radiation Oncology

摘　　要：随着现代放疗技术的进步,术后放疗在根治术后ⅢA-N2期非小细胞肺癌中的地位受到重视。目前,由于缺乏大规模前瞻性的随机对照研究,术后放疗的价值一直受到争议。大量回顾性研究证实术后放疗疗效与不同临床病理特征有很强的相关性,本文对影响术后放疗疗效的因素进行分析总结,探讨术后放疗获益亚组人群,实现精准的术后放疗。With the development of modern radiotherapy technology,the significance of postoperative radiotherapy in treating resectable stageⅢA-N2 non-small cell lung cancer has been emphasized.At present,the value of postoperative radiotherapy has been controversial due to the lack of large-size prospective randomized controlled studies.A large number of retrospective studies have confirmed that the efficacy of postoperative radiotherapy is significantly correlated with different clinicopathological characteristics.In this article,the influencing factors of the efficacy of postoperative radiotherapy were analyzed,and the subgroup of patients receiving clinical benefits was discussed,aiming to achieve precise postoperative radiotherapy.

关 键 词：癌 非小细胞肺/术后放射疗法 治疗结果 研究进展 

分 类 号：R734.2[医药卫生—肿瘤]